Search results
Results from the WOW.Com Content Network
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
Anxiety Medications: An Overview. Anxiety disorders are very common, according to the National Institute of Mental Health. An estimated 31.1 percent of all American adults will experience some ...
Medications for Depression: An Overview. Antidepressants are a class of medications used very commonly to treat depression. In fact, nearly 13 percent of people 12 and over in the U.S. used ...
Saphris – atypical antipsychotic used to treat schizophrenia and bipolar disorder; Serax – anti-anxiety medication of the benzodiazepine class, often used to help during detoxification from alcohol or other addictive substances; Serentil (mesoridazine) – an antipsychotic drug used in the treatment of schizophrenia [1]
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.
According to the Anxiety and Depression Association of America (ADAA), 6.8 million adults have GAD. Other anxiety disorders include obsessive-compulsive disorder, panic disorder, post-traumatic ...
This is an alphabetical list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is not exhaustive. All mentioned drugs here are generic names. Not all drugs listed are used regularly in all countries.
Potential explanations include exacerbating cognitive problems that are already common in anxiety disorders, causing or worsening depression and suicidality, [124] [125] disrupting sleep architecture by inhibiting deep stage sleep, [126] withdrawal symptoms or rebound symptoms in between doses mimicking or exacerbating underlying anxiety or ...